Alhambra Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Alhambra Investment Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,248	Closed	-$689K	–	146
2022 Q4	$689K	Sell	5,248 -65	-1%	-$8.4K	0.5%	60
2022 Q3	$621K	Buy	5,313 +62	+1%	+$7.7K	0.47%	62
2022 Q2	$618K	Buy	5,251 +370	+8%	+$43.9K	0.45%	65
2022 Q1	$636K	Buy	4,881 +696	+17%	+$90.7K	0.42%	69
2021 Q4	$639K	Buy	4,185 +557	+15%	+$86.2K	0.45%	73
2021 Q3	$586K	Buy	3,628 +167	+5%	+$28.1K	0.45%	73
2021 Q2	$566K	Buy	3,461 +168	+5%	+$25.9K	0.42%	76
2021 Q1	$496K	Buy	3,293 +348	+12%	+$55.3K	0.4%	79
2020 Q4	$446K	Buy	2,945 +149	+5%	+$21.3K	0.48%	71
2020 Q3	$379K	Buy	+2,796	New	+$379K	0.46%	75

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Alhambra Investment Management's IBB Position: Q1 2023 in Review

Alhambra Investment Management sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 5,248 shares — an estimated $689K sold.

Alhambra Investment Management first reported a position in IBB in Q3 2020 and held it in 10 quarters. The position peaked at $689K in Q4 2022. 867 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

Alhambra Investment Management reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
Alhambra Investment Management sold 5,248 iShares Biotechnology ETF shares in Q1 2023, an estimated $689K.
Alhambra Investment Management first reported a position in iShares Biotechnology ETF in Q3 2020 and held it in 10 quarters.
Alhambra Investment Management's iShares Biotechnology ETF position peaked at $689K in Q4 2022.
867 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on Alhambra Investment Management's 13F filing for Q1 2023, filed 18 Apr 2023.